Current studies into retatrutide, a dual activator for GLP-1 and GIP receptors, are revealing significant effects in addressing weight gain and diabetes 2 disease. Preclinical evidence suggest a distinct action https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/